Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous buprenorphine/naloxone for neuropathic pain in diabetic neuropathy: preliminary crossover study
2005-001356-20Phase 2Terminated
- Sponsor
- Reckitt
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of buprenorphine and naloxone in Neuralgia and diabetic neuropathy (3 arms), sponsored by Reckitt. Started Feb 2006; status: terminated.
02
Drugs
buprenorphinenaloxone
03
Conditions
Neuralgiadiabetic neuropathy
Beyond the preview
Go deeper on 2005-001356-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001356-20.